Borrelli, Enrico
Querques, Lea
Lattanzio, Rosangela
Cavalleri, Michele
Grazioli Moretti, Alessio
Di Biase, Carlo
Signorino, Alberto
Gelormini, Francesco
Sacconi, Riccardo
Bandello, Francesco
Querques, Giuseppe
Article History
Received: 10 February 2020
Accepted: 17 March 2020
First Online: 3 April 2020
Compliance with ethical standards
:
: E. Borrelli: Recipient—Centervue (Italy); Zeiss (Dublin, USA). R. Sacconi: Recipient—Zeiss (Dublin, USA). Francesco Bandello: Recipient—Alcon (Fort Worth,Texas,USA), Alimera Sciences (Alpharetta, Georgia, USA), Allergan Inc (Irvine, California,USA), Farmila-Thea (Clermont-Ferrand, France), Bayer Shering-Pharma (Berlin, Germany), Bausch And Lomb (Rochester, New York, USA), Genentech (San Francisco, California, USA), Hoffmann-La-Roche (Basel, Switzerland), NovagaliPharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee,Belgium), Zeiss (Dublin, USA). Giuseppe Querques: Recipient—Alimera Sciences (Alpharetta, Georgia, USA), Allergan Inc (Irvine, California, USA), Amgen (Thousand Oaks,USA), Bayer Shering-Pharma (Berlin, Germany), Centervue (Italy); Heidelberg (Germany), KBH (Chengdu; China), LEH Pharma (London, UK), Lumithera (Poulsbo; USA), Novartis (Basel, Switzerland), Sandoz (Berlin, Germany), Sifi (Catania, Italy), Sooft-Fidea (Abano, Italy), Zeiss (Dublin, USA). Other authors: none.
: The study was approved by the Institutional Review Board and adhered to the tenets of the Declaration of Helsinki.
: Informed consent was obtained from all subjects prior to enrollment in the study.